Skip to content

The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis. A Double Blind Randomized Controlled Study.

The Role of Extracorporeal Shock Wave Therapy in the Treatment of Trapezial-Metacarpal Osteoarthritis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01783262
Enrollment
Unknown
Registered
2013-02-04
Start date
2009-12-31
Completion date
Unknown
Last updated
2013-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis Trapezial-metacarpal Joint

Brief summary

Evaluate if extracorporeal shock wave therapy is more effective than sham treatment in patients with trapezial-metacarpal osteoarthritis in pain relief and functional improvement.

Interventions

an energy level of 0.09 mJ/mm2, 2400 pulses once a week for 4 weeks.

DEVICEDevice: Sham extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* according to the Eaton et al. classification the inclusion criteria involved those patients with stage III, participants had to have a history 6 months of pain and they were 18 years of age or older.

Exclusion criteria

were also the presence of degenerative or non-degenerative neurologic conditions, in which pain perception is altered, a history of coagulopathy, cancer, cardiac pacemaker, calcaneal fracture, and pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleThe change in the mean Visual Analogic Scale scores from baseline to 3 and 6 months after the interventionIt is a horizontal line, 10 cm in length with 0 cm labeled no pain and 10 cm labeled worst pain I have ever had. The patient marks on the line the point that they feel represents their perception of their current state
Duruöz Hand Index (DHI)The change in the mean of DHI at 3 and 6 months follow upis a self-report questionnaire which measures hand functional ability detecting how much difficulty the patient has performing eighteen daily tasks of living in reference to hand function. Each item is scored from 0 (performed without difficulty) to 5 (impossible to do). A total score is obtained by adding the scores of all questions (range 0-90). A higher score indicates greater disability. It was found that this scale is reliable and valid in patients with osteoarthritis
Disabilities of the Arm, Shoulder, and Hand questionnaireThe changes in mean at 3 and 6 months follow upIt is a 30-item scale that addresses difficulty in performing various physical activities that require upper extremity function (physical function, 21 items); symptoms of pain, activity-related pain, tingling, weakness, and stiffness (pain symptoms, 5 items); or impact of disability and symptoms on social activities, work, sleep, and psychological well-being (emotional and social function, 4 items). The score ranges from 0 to 100, where 0 disability and 100 most severe disability.

Secondary

MeasureTime frameDescription
grip and pinch testsThe change in mean at 3 and 6 months follow upThe measure of strength by hand grip and pinch tests, for continuous variables that were measured in kilograms with a standard dynamometer

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026